T. Rowe Price Associates’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-885,698
Closed -$48.5M 3104
2022
Q2
$48.5M Buy
885,698
+1,620
+0.2% +$87.6K 0.01% 878
2022
Q1
$43M Buy
884,078
+811,625
+1,120% +$36.3M ﹤0.01% 1021
2021
Q4
$3.02M Buy
72,453
+3,457
+5% +$145K ﹤0.01% 1581
2021
Q3
$2.94M Sell
68,996
-3,513
-5% -$158K ﹤0.01% 1613
2021
Q2
$3.6M Sell
72,509
-12,809
-15% -$678K ﹤0.01% 1577
2021
Q1
$4.61M Sell
85,318
-7,408
-8% -$384K ﹤0.01% 1484
2020
Q4
$4.81M Sell
92,726
-54,790
-37% -$2.6M ﹤0.01% 1448
2020
Q3
$6.43M Sell
147,516
-137,414
-48% -$6.11M ﹤0.01% 1370
2020
Q2
$11.8M Sell
284,930
-57,951
-17% -$2.23M ﹤0.01% 1262
2020
Q1
$11.3M Sell
342,881
-677
-0.2% -$32.3K ﹤0.01% 1214
2019
Q4
$18.8M Buy
343,558
+5,002
+1% +$257K ﹤0.01% 1206
2019
Q3
$16.3M Sell
338,556
-62,008
-15% -$2.97M ﹤0.01% 1208
2019
Q2
$19.8M Sell
400,564
-1,403
-0.3% -$75.1K ﹤0.01% 1179
2019
Q1
$23.6M Sell
401,967
-3,697,689
-90% -$202M ﹤0.01% 1126
2018
Q4
$196M Sell
4,099,656
-1,213,141
-23% -$64M 0.03% 442
2018
Q3
$332M Sell
5,312,797
-46,378
-0.9% -$2.94M 0.05% 366
2018
Q2
$349M Sell
5,359,175
-178,636
-3% -$11.6M 0.05% 341
2018
Q1
$351M Sell
5,537,811
-151,788
-3% -$10.6M 0.06% 329
2017
Q4
$406M Buy
5,689,599
+421,489
+8% +$28.3M 0.07% 306
2017
Q3
$332M Buy
5,268,110
+5,185,322
+6,263% +$327M 0.06% 344
2017
Q2
$5.14M Buy
82,788
+6,799
+9% +$426K ﹤0.01% 1413
2017
Q1
$4.94M Buy
75,989
+376
+0.5% +$24.1K ﹤0.01% 1430
2016
Q4
$4.51M Buy
75,613
+1,215
+2% +$69.5K ﹤0.01% 1435
2016
Q3
$4.27M Buy
74,398
+1
+0% +$58 ﹤0.01% 1442
2016
Q2
$4.13M Sell
74,397
-6,188
-8% -$320K ﹤0.01% 1422
2016
Q1
$3.75M Buy
80,585
+11,565
+17% +$515K ﹤0.01% 1433
2015
Q4
$3.28M Buy
69,020
+4,725
+7% +$229K ﹤0.01% 1475
2015
Q3
$3.07M Buy
64,295
+2,486
+4% +$126K ﹤0.01% 1500
2015
Q2
$3.34M Sell
61,809
-209,945
-77% -$10.8M ﹤0.01% 1525
2015
Q1
$12.7M Buy
271,754
+1,486
+0.5% +$67.8K ﹤0.01% 1268
2014
Q4
$11M Buy
+270,268
New +$9.57M ﹤0.01% 1299

Other funds holding CDK